Purchase Order 36C24925P0605

Award Date 6/16/25
Potential Completion Date 7/16/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40502, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune system, a cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) for the delivery of Optune medical devices, transducer arrays, rental...
This federal contract award to Novocure Inc., a foreign-owned manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price delivery order awarded under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This multiple-award...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducer devices and associated support services. The $33,165.82 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022. This contract enables the VA to efficiently...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the provision of the Optune transducer system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $49,748.73, is a delivery order under Novocure's $28.85 million Federal Supply...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the delivery of the Optune Plus Transducers system to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $33,165.82 and is structured as a firm fixed-price delivery order, running through June 30, 2025. Novocure, acting as the prime contractor, will provide the Optune medical devices, transducer arrays, rental equipment,...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order contract to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, for the provision of Optune Plus transducers and related cancer therapy support services. The contract, valued at $49,748.73, has a completion date of September 8, 2024, and was issued under Novocure's existing 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract (Award ID: 36C26223P0309), with a ceiling value of $16,582.91, is a Firm Fixed Price Purchase Order placed under...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 delivery order contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award is for the provision of Novocure Inc.'s proprietary Optune Tumor Treating Fields (TTFields) therapy products and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order was issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. The contract does not utilize any set-aside designations....

This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune device, a specialized cancer therapy technology utilizing Tumor Treating Fields (TTFields). The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order with a completion date of July 16, 2025.

Novocure holds a significant $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which serves as the primary procurement vehicle for the VA to obtain Novocure's Optune line of medical devices, transducer arrays, rental equipment, and associated support services. Under this FSS contract, various VA regional networks, including the Veterans Integrated Service Network 9 (VISN 9), have issued delivery orders to Novocure to enable the VA to expand veterans' access to this innovative, non-invasive cancer treatment technology across multiple medical facilities nationwide. The contract does not utilize any set-aside designations.

Generated 7/1/25, 11:05 AM